Successful treatment of atopic dermatitis refractory to dupilumab with baricitinib.

Lee, Dong Heon; Park, So Yun; Hong, Narang; Kook, Hyung Don; Jung, Hye Jung; Park, Mi Youn; Ahn, Jiyoung

Lee, Dong Heon; Park, So Yun; Hong, Narang; Kook, Hyung Don; Jung, Hye Jung; Park, Mi Youn; Ahn, Jiyoung.

Afiliación

Lee DH; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Park SY; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Hong N; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Kook HD; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Jung HJ; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Park MY; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Ahn J; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.

Dermatol Ther ; 35(11): e15802, 2022 11.

Article en En | MEDLINE | ID: mdl-36043599

Asunto(s)

Azetidinas; Dermatitis Atópica; Humanos; Dermatitis Atópica/diagnóstico; Dermatitis Atópica/tratamiento farmacológico; Anticuerpos Monoclonales Humanizados; Azetidinas/uso terapéutico; Resultado del Tratamiento; Índice de Severidad de la Enfermedad

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Azetidinas / Dermatitis Atópica Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google